ProThera Biologics Inc. Secures $500,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=23707538-fc2a-451f-b536-2b21f69ed9b1&Preview=1
Date
6/24/2008
Company Name
ProThera Biologics Inc.
Mailing Address
551 Warren Avenue East Providence, RI 02914
Company Description
The mission of the company is to develop novel products that exploit the promise of personalized medicine by leveraging on its proprietary technology of natural serine protease inhibitor proteins.
The company focuses on unmet medical needs by developing INTEGRATED theranostic and therapeutic biomolecules for serious human diseases such as sepsis and cancer.
Website
http://www.protherabiologics.com
Transaction Type
Venture Equity
Transaction Amount
$500,000
Transaction Round
Undisclosed
Proceeds Purposes
Richard Horan of the Slater Technology Fund said, “With additional investment and with Rick Andrews coming on-board, we are excited about the prospects of accelerating the company’s efforts in the development of what promise to be significant advances in clinical medicine.”
M&A Terms
Venture Investor
Slater Technology Fund